Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2016 December;151(6) > Giornale Italiano di Dermatologia e Venereologia 2016 December;151(6):610-8





Rivista di Dermatologia e Malattie Sessualmente Trasmesse

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014




Giornale Italiano di Dermatologia e Venereologia 2016 December;151(6):610-8

lingua: Inglese

Electrochemotherapy in non-melanoma head and neck skin cancers: a three-center experience and review of the literature

Roberta ROTUNNO 1, Federica MARENCO 2, Simone RIBERO 2, Stefano CALVIERI 1, Paolo AMERIO 3, Pietro CURATOLO 1, Pietro QUAGLINO 2

1 Dermatology and Plastic Surgery Clinic, “Sapienza” University, Rome, Italy; 2 Dermatology Clinic, Molinette Hospital, University of Turin, Turin, Italy; 3 Dermatology Clinic, “Gabriele D’Annunzio” University of Chieti-Pescara, Chieti, Italy


BACKGROUND: The main purposes of this study were to evaluate the efficacy of electrochemotherapy in head and neck tumors, to assess local tumor control, its safety profile and its impact on the patients’ quality of life.
METHODS: This is a multicenter prospective, non-randomized phase II trial. This trial was carried out at the Dermatology Clinic of the “Sapienza” University of Rome, at the Dermatology Clinic of the University of Chieti and at the Dermatology Clinic of the University of Turin. Fifty-five patients with head and neck cancer were recruited. Electrochemotherapy was carried out according to the ESOPE guidelines. Statistical analyses were performed using Stata/SE v.12.0 Statistical Software.
RESULTS: A significant clinical response was achieved in 50/55 patients with 91% of objective response rate (OR). Thirty-three out of 55 patients showed a complete response (CR) (60%); 17 treated patients had a partial response (PR) (31%). A significantly higher CR rate was obtained in patients not previously treated by surgery (15/19; 79%), with respect to those with a previous excision of the tumor (14/30; 47%) (P=0.025). An additional parameter influencing response is represented by anesthesia: patients treated by ECT with general anesthesia were characterized by significantly higher CR rate (68%) than those treated with local anesthesia (27%) (P=0.014).
CONCLUSIONS: Our experience confirmed high efficiency in local tumor control, excellent toxicity profile, tissue preservation with good cosmetic and functional results, even with repeated applications. ECT can represent a first­line treatment in the local management of head and neck cancers.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail